Westpac Banking Corp’s Merck MRK Stock Holding History

Westpac Banking Corp’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.31M	Sell	35,819 -22,263	-38%	-$2.57M	0.3%	88
2025 Q4	$6.11M	Sell	58,082 -63,983	-52%	-$6.01M	0.39%	57
2025 Q3	$10.2M	Buy	122,065 +1,489	+1%	+$123K	0.63%	27
2025 Q2	$9.54M	Buy	120,576 +3,253	+3%	+$259K	0.64%	29
2025 Q1	$10.5M	Sell	117,323 -5,912	-5%	-$552K	0.77%	22
2024 Q4	$12.3M	Buy	123,235 +20,491	+20%	+$2.11M	0.81%	20
2024 Q3	$11.7M	Buy	102,744 +12,644	+14%	+$1.5M	0.78%	21
2024 Q2	$11.2M	Buy	90,100 +637	+0.7%	+$82.1K	0.88%	16
2024 Q1	$11.8M	Sell	89,463 -14,795	-14%	-$1.82M	0.9%	18
2023 Q4	$11.4M	Sell	104,258 -19,270	-16%	-$2M	0.94%	14
2023 Q3	$12.7M	Buy	123,528 +12,628	+11%	+$1.36M	0.95%	16
2023 Q2	$12.8M	Sell	110,900 -323,725	-74%	-$36.8M	0.9%	17
2023 Q1	$46.2M	Sell	434,625 -47,983	-10%	-$5.18M	0.62%	19
2022 Q4	$53.5M	Buy	482,608 +76,911	+19%	+$7.86M	0.79%	12
2022 Q3	$34.9M	Buy	405,697 +17,888	+5%	+$1.6M	0.53%	25
2022 Q2	$35.4M	Buy	387,809 +36,953	+11%	+$3.28M	0.46%	37
2022 Q1	$28.8M	Sell	350,856 -16,248	-4%	-$1.28M	0.33%	68
2021 Q4	$28.1M	Sell	367,104 -13,632	-4%	-$1.09M	0.29%	80
2021 Q3	$28.6M	Sell	380,736 -7,643	-2%	-$581K	0.31%	71
2021 Q2	$30.2M	Sell	388,379 -32,123	-8%	-$2.39M	0.3%	66
2021 Q1	$30.9M	Buy	420,502 +10,795	+3%	+$796K	0.34%	64
2020 Q4	$32M	Buy	409,707 +12,791	+3%	+$978K	0.36%	56
2020 Q3	$31.4M	Buy	396,916 +5,745	+1%	+$450K	0.43%	42
2020 Q2	$28.9M	Sell	391,171 -22,649	-5%	-$1.71M	0.43%	42
2020 Q1	$30.4M	Buy	413,820 +8,325	+2%	+$654K	0.52%	26
2019 Q4	$35.2M	Buy	405,495 +34,425	+9%	+$2.83M	0.45%	36
2019 Q3	$29.8M	Sell	371,070 -21,597	-6%	-$1.73M	0.41%	49
2019 Q2	$31.4M	Buy	392,667 +19,741	+5%	+$1.51M	0.48%	44
2019 Q1	$29.6M	Sell	372,926 -1,176	-0.3%	-$88K	0.49%	44
2018 Q4	$27.3M	Buy	374,102 +15,596	+4%	+$1.1M	0.46%	46
2018 Q3	$24.3M	Sell	358,506 -1,258	-0.3%	-$80.1K	0.42%	52
2018 Q2	$20.8M	Sell	359,764 -1,917	-0.5%	-$108K	0.4%	63
2018 Q1	$18.8M	Buy	361,681 +86,719	+32%	+$4.68M	0.38%	67
2017 Q4	$14.8M	Buy	274,962 +7,604	+3%	+$422K	0.34%	82
2017 Q3	$16.3M	Sell	267,358 -6,586	-2%	-$399K	0.36%	65
2017 Q2	$16.8M	Sell	273,944 -544,509	-67%	-$33.1M	0.37%	60
2017 Q1	$49.6M	Buy	818,453 +262,853	+47%	+$15.9M	0.4%	62
2016 Q4	$38.3M	Buy	555,600 +38,456	+7%	+$2.25M	0.36%	71
2016 Q3	$27.2M	Sell	517,144 -77,817	-13%	-$4.55M	0.29%	83
2016 Q2	$27.4M	Sell	594,961 -29,761	-5%	-$1.58M	0.3%	79
2016 Q1	$28.1M	Sell	624,722 -88,842	-12%	-$4.35M	0.31%	73
2015 Q4	$36M	Sell	713,564 -190,512	-21%	-$9.61M	0.4%	56
2015 Q3	$42.6M	Sell	904,076 -146,596	-14%	-$7.79M	0.47%	43
2015 Q2	$57.1M	Sell	1,050,672 -229,436	-18%	-$12.9M	0.56%	33
2015 Q1	$82.2M	Sell	1,280,108 -282,163	-18%	-$16M	0.71%	27
2014 Q4	$84.7M	Buy	1,562,271 +233,041	+18%	+$13M	0.81%	24
2014 Q3	$75.2M	Buy	1,329,230 +255,779	+24%	+$14.4M	0.73%	27
2014 Q2	$59.3M	Buy	1,073,451 +174,042	+19%	+$9.49M	0.57%	33
2014 Q1	$48.7M	Buy	899,409 +290,026	+48%	+$15M	0.52%	39
2013 Q4	$29.1M	Sell	609,383 -132,298	-18%	-$6.05M	0.33%	60
2013 Q3	$33.7M	Sell	741,681 -459,388	-38%	-$21M	0.42%	46
2013 Q2	$51.8M	Buy	+1,201,069	New	+$53.6M	0.79%	21

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westpac Banking Corp's MRK Position: Q1 2026 in Review

Westpac Banking Corp reduced its Merck (MRK) stake by 38% in Q1 2026, selling an estimated $2.57M and leaving 35,819 shares worth $4.31M. The position accounts for 0.3% of the portfolio, ranked #88.

Westpac Banking Corp first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $84.7M in Q4 2014. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Westpac Banking Corp held 35,819 shares of Merck worth $4.31M as of Q1 2026.
Westpac Banking Corp sold 22,263 Merck shares in Q1 2026, an estimated $2.57M.
Merck made up 0.3% of Westpac Banking Corp's portfolio in Q1 2026, its #88 holding.
Westpac Banking Corp first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Westpac Banking Corp's Merck position peaked at $84.7M in Q4 2014.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.